Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Medi-First Burn

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 20 g/1 L
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
September 8, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Lidocaine Hydrochloride 20 g/1 L
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
September 8, 2025
Manufacturer
Unifirst First Aid Corporation
Registration number
M015
NDC root
47682-255
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Medi-First Burn Spray is a topical analgesic designed to provide temporary pain relief for minor burns. It contains 2.0% lidocaine HCl, which helps alleviate discomfort associated with these injuries. This pump spray format makes it easy to apply directly to the affected area, offering a convenient solution for managing pain from minor burns.

Uses

If you’re dealing with minor burns, this medication can provide temporary relief from the pain associated with those injuries. It’s specifically designed to help ease the discomfort you might feel from minor burns, allowing you to manage your symptoms more effectively.

Rest assured, this medication does not have any known teratogenic effects (which means it won't cause birth defects) or nonteratogenic effects. This makes it a safe option for those in need of pain relief from minor burns.

Dosage and Administration

To use the burn spray effectively, start by cleaning the affected area thoroughly. Once it's clean, spray an even layer of the burn spray over the area. You can do this up to 3 to 4 times a day, but make sure not to exceed this limit for the best results.

It's important to note that this burn spray is not recommended for children under 12 years of age, so please keep that in mind when considering its use. Always follow these guidelines to ensure safe and effective treatment.

What to Avoid

It's important to use this product safely to avoid any potential issues. You should not apply it in large amounts, especially on raw or blistered skin, as this could lead to irritation or other complications. Additionally, be careful not to use it near your eyes; if it does come into contact with your eyes, rinse them thoroughly with water to prevent discomfort.

While there are no specific contraindications or concerns about abuse, misuse, or dependence associated with this product, following these guidelines will help ensure your safety and well-being.

Side Effects

When using this product, it's important to remember that it is for external use only. If your condition worsens or does not improve after 7 days, or if it clears up and then returns, you should stop using the product and consult your doctor. This ensures that you receive the appropriate care and guidance for your health.

Warnings and Precautions

This product is for external use only, so please avoid using it on any internal areas of your body. Keep it out of reach of children, and if it is swallowed, seek medical help or contact a Poison Control Center immediately.

If your condition worsens, persists for more than 7 days, or clears up and then returns, stop using the product and call your doctor for further advice. Your health and safety are important, so don’t hesitate to reach out for help if you need it.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency services or go to the nearest hospital. Always keep your medications in a safe place and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

It’s important to note that there is currently no information available about the use of Medi-First Burn (lidocaine hcl spray) during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been established.

If you are pregnant or planning to become pregnant, it’s best to consult with your healthcare provider before using this product to ensure it is safe for you and your baby. Always prioritize open communication with your doctor regarding any medications you may consider during this time.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or considerations regarding the use of this product while nursing. This means that it is not expected to affect your milk production or pose any risk to your infant through breast milk. Always consult with your healthcare provider if you have any concerns or questions about medications while breastfeeding.

Pediatric Use

It's important to know that this medication should not be used in children under 12 years of age. If you have a child in this age group, please consult your healthcare provider for alternative options that are safe and appropriate for their age. Always prioritize your child's health and follow medical advice regarding their treatment.

Geriatric Use

When considering medication for older adults, it's important to note that this particular drug is not recommended for children under 12 years of age. If you are caring for an older adult, ensure that any medications are appropriate for their age and health status. Always consult with a healthcare professional to discuss any specific concerns or questions regarding medication use in older individuals.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not include special monitoring or safety considerations tailored for patients with renal impairment (kidney issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your health situation. They can help you understand how your kidney function may affect your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no established recommendations for how your liver health might affect the use of this medication.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and appropriate for your liver health. They can help you understand how to manage your condition while considering any medications you may need.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any lab tests you may be undergoing. This way, you can receive the best possible care tailored to your needs.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dry place at a temperature between 68°F and 77°F (20°C to 25°C). This temperature range helps maintain the integrity of the device.

When handling the product, be sure to follow any specific instructions provided to avoid contamination or damage. Always keep it in a clean environment to ensure it remains safe for use. If you have any questions about disposal or further handling, consult the guidelines provided with your product.

Additional Information

You should apply the burn spray topically, which means you will spray an even layer over the cleaned affected area. It is recommended to do this no more than 3 to 4 times a day for best results. There are no additional details available regarding laboratory tests, abuse potential, or patient counseling.

FAQ

What is Medi-First Burn Spray used for?

Medi-First Burn Spray is used for temporary pain relief associated with minor burns.

How should I use Medi-First Burn Spray?

Spray an even layer over the cleaned affected area not more than 3-4 times daily.

Is there any age restriction for using this spray?

Medi-First Burn Spray should not be used on children under 12 years of age.

What should I do if my condition worsens?

Stop use and ask your doctor if the condition worsens or persists for more than 7 days.

Are there any contraindications for this product?

No specific contraindications are mentioned for Medi-First Burn Spray.

What are the storage conditions for Medi-First Burn Spray?

Store the spray at 68°-77°F (20°-25°C).

Can I use Medi-First Burn Spray near my eyes?

No, do not use it near your eyes; if contact occurs, rinse thoroughly with water.

Is there any information about using this spray during pregnancy?

There is no information regarding the use of Medi-First Burn Spray during pregnancy.

What should I do if I accidentally swallow the spray?

Keep out of reach of children and seek medical help or contact a Poison Control Center immediately if swallowed.

Packaging Info

Below are the non-prescription pack sizes of Medi-First Burn (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Medi-First Burn.
Details

Drug Information (PDF)

This file contains official product information for Medi-First Burn, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of pain associated with minor burns. It effectively alleviates pain in patients experiencing discomfort due to such injuries.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The burn spray should be applied as an even layer over the cleaned affected area. The recommended frequency of application is not more than 3 to 4 times daily.

This product is contraindicated for use in children under 12 years of age. Healthcare professionals should ensure that the area is properly cleaned prior to application to maximize the effectiveness of the treatment.

Contraindications

Use is contraindicated in the following situations:

Application in large quantities, especially over raw or blistered areas, is not recommended due to the potential for increased irritation or adverse effects. Additionally, the product should not be applied near the eyes; in the event of contact, it is essential to rinse thoroughly with water to prevent irritation.

Warnings and Precautions

For external use only. It is imperative that this product is applied solely to the skin and not ingested.

General precautions must be observed to ensure safety. This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens, persists for more than 7 days, or if symptoms resolve and then return. Monitoring for these signs is essential to ensure appropriate management of the patient's condition.

No specific laboratory tests are recommended for the safe use of this product, and there are no additional emergency medical help instructions provided.

Side Effects

For external use only. Patients should discontinue use and consult a healthcare professional if the condition worsens or persists for more than 7 days, or if the condition clears up and then returns.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Medi-First Burn (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Medi-First Burn.
Details

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. Safety and efficacy have not been established in this population, and therefore, it is contraindicated for children in this age group. Healthcare professionals should consider alternative treatments for pediatric patients who fall within this age range.

Geriatric Use

Elderly patients may require careful consideration when prescribing this medication. It is important to note that this medication is not indicated for use in children under 12 years of age.

Healthcare providers should assess the overall health status and comorbidities of geriatric patients, as these factors may influence the safety and efficacy of the treatment. Monitoring for potential adverse effects is recommended, given that elderly patients may have altered pharmacokinetics and pharmacodynamics.

Dose adjustments may be necessary based on individual patient response and tolerance. Regular evaluation of the patient's condition and medication regimen is advised to ensure optimal therapeutic outcomes while minimizing risks.

Pregnancy

There is currently no information available regarding the use of Medi-First Burn (lidocaine hcl spray) during pregnancy. This includes any safety concerns, dosage modifications, or special precautions that may be necessary for pregnant patients. Healthcare professionals should exercise caution when considering the use of this medication in women who are pregnant or may become pregnant, as the potential effects on fetal outcomes are not established. It is advisable to weigh the benefits against any unknown risks when prescribing this medication to pregnant patients.

Lactation

There are no specific warnings or considerations regarding the use of this product by lactating mothers. Additionally, there are no known concerns related to the potential for excretion in breast milk or associated risks for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, no dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function are specified in the prescribing information. Healthcare professionals should exercise caution and consider the individual clinical scenario when prescribing this medication to patients with liver problems.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate supportive care in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help immediately or contact a Poison Control Center for assistance. It is important for patients to understand the urgency of the situation and the necessary steps to take if an accidental ingestion occurs.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 68° to 77°F (20° to 25°C) to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent any degradation of the product.

Additional Clinical Information

The product is administered topically, with the recommended application being an even layer of burn spray over the cleaned affected area. This should not exceed 3-4 times daily.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Medi-First Burn, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Medi-First Burn, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.